The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-1 inhibitor plus chemotherapy as 2nd/subsequent line therapy had similar clinical outcome with PD-1/PD-L1 inhibitor monotherapy in advanced NSCLC.
 
Xiaoyang Zhai
No Relationships to Disclose
 
Yaru Tian
No Relationships to Disclose
 
Weiwei Yan
No Relationships to Disclose
 
Ning An
No Relationships to Disclose
 
Hui Zhu
No Relationships to Disclose